Association between blood eosinophil count with asthma hospital readmissions

Area of Science:

• Pulmonology
• Clinical Immunology
• Epidemiology

Background:

• Eosinophils play a role in asthma pathophysiology.
• The prognostic value of blood eosinophil count (BEC) in asthma is debated.
• Understanding BEC's impact on asthma readmissions is crucial for patient management.

Purpose of the Study:

• To investigate the association between blood eosinophil count (BEC) and hospital readmissions in asthma patients.
• To determine if BEC levels can predict the risk of asthma exacerbation readmissions.

Main Methods:

• Retrospective review of 1316 adult asthma admissions from 2000-2010.
• Blood eosinophil count (BEC) measured from initial hospital samples.
• Analysis of early, late, and frequent readmissions using BEC thresholds (≥150, ≥200, ≥300, ≥400 cells/μL).

Main Results:

• Mean BEC was 201.7 cells/μL in 1316 patients (70% female, mean age 60).
• A BEC ≥300 cells/μL was linked to a 42% reduced risk of late readmission.
• A BEC ≥400 cells/μL correlated with a 41% reduced risk of late readmission and 63% reduced risk of frequent late readmission.

Conclusions:

• Elevated blood eosinophil counts are associated with a lower incidence of asthma hospital readmissions.
• Higher BEC may indicate a better prognosis regarding asthma exacerbation recurrence.
• BEC could serve as a predictive biomarker for reduced asthma readmission rates.